A real-world comparison of cisplatin vs cetuximab used concurrently with radiation in the treatment of locally advanced oropharyngeal carcinoma.
Andrea S FungArfan Raheen AfzalRobyn BanerjeeBrock DebenhamDesiree HaoPublished in: Head & neck (2020)
Our data reaffirm results from randomized studies showing better survival outcomes with cis-RT compared to cetux-RT even among those who are >65 with CCI ≥3.